The Analyst Verdict: Olin In The Eyes Of 9 Experts

Apr 3, 2024 · The Analyst Verdict: Olin In The Eyes Of 9 Experts. Benzinga. Apr. 3, 2024, 09:00 AM. ... Stay up to date on Olin analyst ratings. Unveiling the Story Behind Olin.

CouponFollow Extension

$63
OFF

The Analyst Verdict: Olin In The Eyes Of 9 Experts | CapEdge

3 weeks from now

The Analyst Verdict: Olin In The Eyes Of 9 Experts. Company Profile < Back. Share this news. Latest OLN news. RBC Capital Maintains Outperform on Olin, Lowers Price Target to $63. 29 …

capedge.com

$67.14
OFF

The Analyst Verdict: Synchrony Finl In The Eyes Of 18 Experts

3 weeks from now

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $67.14, a high estimate of $85.00, and a low estimate of $40.00.

nasdaq.com

$67.62
OFF

Expert Outlook: Olin Through The Eyes Of 8 Analysts

3 weeks from now

Jul 10, 2024 · Analysts have set 12-month price targets for Olin, revealing an average target of $67.62, a high estimate of $75.00, and a low estimate of $51.00.

nasdaq.com

$18
OFF

The Analyst Verdict: Banc Of California In The Eyes Of 11 Experts

3 weeks from now

2 days ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $18.0, along with a high estimate of $20.00 and a low estimate …

benzinga.com

$60.56
OFF

The Analyst Verdict: Las Vegas Sands In The Eyes Of 9 Experts

3 weeks from now

5 days ago · In the assessment of 12-month price targets, analysts unveil insights for Las Vegas Sands, presenting an average target of $60.56, a high estimate of $69.00, and a low estimate …

nasdaq.com

$25.56
OFF

The Analyst Verdict: American Eagle Outfitters In The Eyes Of 9 …

3 weeks from now

Apr 9, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $25.56, a high estimate of $31.00, and a low estimate of $19.00.

businessinsider.com

$38.67
OFF

The Analyst Verdict: Cadence Bank In The Eyes Of 9 Experts

3 weeks from now

Dec 5, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $38.67, a high estimate of $45.00, and a low estimate of $35.00.

nasdaq.com

$4
OFF

The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 …

3 weeks from now

4 days ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $4.0, along with a high estimate of $9.00 and a low estimate of …

nasdaq.com